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As one of the possible treatments for cardiovascular disease (CVD), bypass grafting in 
small diameter vessel (≤ 6 mm diameter) is often employed. However, maintaining the patency of 
this small diameter graft remains a challenge despite 50 years of research in this area. While ePTFE 
graft performance as a large diameter vascular graft is commendable and has been widely used in 
patients, the performance of ePTFE small diameter vascular graft is disappointing with 65% graft 
patency rate at 1 year.1 It was observed that graft occlusion is caused mainly by thrombus or intima 
hyperplasia (IH) formation.  This study proposes the use of sodium trimetaphosphate (STMP) 
crosslinked polyvinyl alcohol (PVA) as small diameter vascular graft due to its low 
thrombogenicity and excellent mechanical property. However, PVA hydrophilicity is known to 
hinder any extracellular matrix (ECM) protein or cell attachment on its surface, while surface 
endothelialisation is believed to prevent thrombus and IH formation. We hypothesize that NH3 
plasma luminal modification on the luminal surface of PVA along with hydrogel patterning with 
microtopography can improve surface interaction with endothelial cells. Additionally, we 
speculate the effect of terminal sterilization step on PVA grafts is minimum and the grafts can 
maintain its patency at 28 to 30-day timepoint.  
Endothelial cell attachment on PVA surface was found to improve on plasma treated 
luminal surface with 2 µm gratings topography. Endothelial gene expressions (PECAM1 and 
NOS3) were, however, found to be downregulated on plasma treated substrates. However, platelet 
and fibrin activation of the microgratings topography done with baboon ex vivo shunt model was 
comparable or lower than ePTFE graft control and collagen coated glass conduit. Furthermore, 
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sterilization of PVA graft with γ-radiation was not found to have any toxic effect on cells and 
interestingly improve endothelialisation. While EtO sterilization was shown to alter PVA 
mechanical and material properties, γ-radiation only affected PVA graft mechanical compliance. 
Gamma irradiated small diameter PVA graft (2 mm ID) without any surface topography was 
implanted with end-to-side anastomoses at the right common carotid artery to assess PVA 
performance over 28-30 days in rabbit models. Five out of 7 PVA grafts were found patent after 
28-30 days of implantation, while only 1 out of 2 ePTFE grafts were patent after 28-30 days. 
Endothelialisation of PVA graft in vivo was, however, not yet observed which compels the 
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1.1 Cardiovascular disease (CVD) and disease treatment 
Cardiovascular diseases (CVD) are the number one cause of death globally.2 Two leading 
types of CVD, ischaemic heart disease and stroke have affected more than 8 million people in 
2015. The early pathology of ischaemic heart disease and stroke begins with a condition called 
atherosclerosis where lipid, cholesterol, and other substances in the blood circulation accumulate 
and form a plaque which eventually causes obstruction to the blood flow. Surrounding tissues that 
do not receive enough oxygen and will eventually die (ischemia) and depending on what type of 
tissues is affected, it can lead to other cardiovascular diseases. In the case of ischaemic heart 
disease and stroke, the tissues experiencing ischemia are heart and brain tissues respectively. 
There are 2 treatments that are commonly performed to reduce vessel stenosis and to 
increase blood flow. The first treatment called angioplasty and stenting is a way to push the plaque 
onto the vessel wall by using an inflated balloon and a vascular stent which are inserted through a 
catheter. The treatment is slightly invasive and is preferred at mild CVD stage. It is noted, however, 
that due to various factors including lifestyle and genetics, the restenosis of the vessel lumen can 
happen. The restenosis can be caused by new plaque build up or neointima formation due to scar 
at the internal vessel wall created by the assembled stent. In a more severe case (multiple vascular 
occlusions along the vessel), however, angioplasty and stenting are not feasible to be done. The 
second treatment option to tackle the vessel obstruction is through implantation of vascular graft 
that bypass the blocked area in the vessel. 
  The gold standard of vascular graft remains the autologous graft which possesses 
matching physiological properties with the surrounding native vessels. However, autologous graft 
is limited in availability and the use of this graft type creates relatively milder injury at the donor 
site. With this consideration, cryopreserved homograft from cadaver became an alternative option 
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to autologous graft. As in any other biological vascular grafts outside autologous graft, homograft 
imposes immunogenic concern which requires patients to take a continuous dose of 
immunosuppressant. More importantly, a study shows that the Young’s modulus of homograft is 
altered due to cryopreservation of the blood vessel3. Due to the complexity in the homograft 
cryopreservation, this option was abandoned by many in 1960s. Meanwhile, allograft (same source 
species) and xenograft (different source species) have similar concern pertaining to immunogenic 
reaction and disruption of vascular intima fiber upon decellularization4. Also, without re-
endothelialisation of the decellularized graft, the extra-cellular matrix left behind is likely to be 
platelet-activating. Due to these limitations, the development of synthetic vascular graft has, 
therefore, attracted clinicians’ attention. The preparation of synthetic vascular graft is in general 
faster (eliminating the need of donor) and less costly, especially in a large-scale fabrication, 
providing an off the shelf option for a vascular graft. 
1.2 Factors influencing the development of thrombus and intimal hyperplasia in vivo  
As any other bypass graft implants, synthetic vascular grafts also face pathological issue 
called intimal hyperplasia (IH) where smooth muscle cells proliferate and create layers of intima 
tissue which lead to stenosis of graft starting from the anastomosis region. IH is believed to be 
caused by shear stresses against the vessel wall (oscillatory shear stress, shear stress gradient, 
turbulence) and vessel wall injury that gives signal to the endothelial cells to trigger the migration 
and proliferation of smooth muscle cells into the lumen.5 In bypass vascular graft application, IH 
is usually formed at the anastomosis between graft and vessel. Not only does the bypass graft 
configuration create a flow bifurcation and hence an increase in wall shear stress on the internal 
side of the bifurcation, but also this configuration magnifies the mechanical compliance/ 
distensibility mismatch between native vessel and graft materials, creating concentrated stress 
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along the suture line at the graft anastomoses and vascular injury.6 The first cause of IH is, 
however, unavoidable because it is technically simpler to implant graft with an end-to-side 
anastomosis configuration rather than with an end-to-end anastomosis configuration and disturb 
the native vessel pre-tension too much, especially in a multiple artherosclerosis case along the 
vessel. The second IH cause (mechanical compliance mismatch) is what most vascular graft 
researchers are studying and trying to achieve. In fact, ePTFE small diameter graft failure is 
believed to be mainly caused by its high stiffness.7 
In addition to IH, synthetic vascular grafts can also be clogged by thrombus when 
implanted. According to Rudolf Virchow’s triad, there are three factors that affect thrombogenesis; 
these include circulatory stasis, vascular wall injury, and hypercoagulable state.8 The first factor, 
circulatory stasis, refers to the hemodynamic in blood vessels whereby irregularity in blood flow 
(oscillatory flow) can cause the deposition of plaque at the vessel wall and the subsequent plaque 
rupture which causes thrombus formation. One example of this would be plaque deposition at 
carotid sinus near the bifurcation. The increase in vessel volume at the sinus causes a sudden 
pressure-drop and creates an oscillatory flow region. Moreover, arrhythmia patients are known to 
have higher chance of forming thrombus in their vessel. The second factor, vascular wall injury, 
refers to the injury mainly caused by surgical intervention, for example, bleeding after the 
anastomosing of a vascular graft to the native vessel, or after having hemodialysis puncture. The 
last factor, hypercoagulable state, refers to abnormal state of the blood coagulation cascade caused 
by anomaly of blood platelet or of fibrinolysis process.9 This state can also be caused by an 
increased level of estrogen in blood or by inflammation in some body parts. From the three 




 Both IH and thrombus problems are more critical in small diameter vascular graft bypass 
where a small degree of stenosis can cause a complete lumen obstruction and a graft failure.  
1.3 Endothelial cell functions and importance in vascular graft application 
 In blood vessels, endothelial cells lining functions as a barrier between blood and the 
outside environment, and depending on where the vessel is located, these cells may be surrounded 
by layers of elastic tissue, smooth muscle cells, and fibrous tissue. As a barrier, endothelial cells 
regulate hemostasis which means maintaining the stability of blood circulation through activating 
coagulation process in case of injury.10 These cells are responsible to send signal to platelet to form 
an initial platelet plug at the injured area and to coagulation factors which activate fibrinogen to 
become fibrin and strengthen the plug forming a clot tissue. In a normal condition, through sensing 
the increase in wall shear stress, endothelial cell secretes nitric oxide (NO) to cause smooth muscle 
cells underlying them to relax and subsequently dilate vessel diameter.11 Moreover, endothelial 
cells control the proliferation and migration of the smooth muscle cells by secreting enzyme and 
inhibitors to the enzyme.12 The presence of endothelial cells lining also prevents the activation of 
platelet and subsequent thrombogenesis.  
Promoting endothelialisation on the vascular graft lumen, therefore, becomes one of the 
main focus in vascular engineering research and goes hand-in-hand with the improvement of graft 
mechanical compliance to match native vessel compliance. 
1.4 Small diameter expanded polytetrafluoroethylene (ePTFE) vascular graft 
ePTFE was discovered in 1969 and has a better tensile strength compared to the high-
density PTFE. Due to its high porosity, the production of ePTFE is less costly. ePTFE can be 
manufactured through polymerization of C2F4 monomer with the addition of peroxide. Because it 
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is biologically inert, biocompatible, and it can be made into tubular shape, ePTFE is used to 
fabricate vascular grafts for over 30 years. The use of ePTFE as vascular graft is notably decent in 
patency for large diameter vascular graft (graft inner diameter > 6 mm); however, the patency of 
small diameter ePTFE vascular graft still requires improvement. 
Due to the rigidity of ePTFE material, kinking is a problem for this graft in the early days. 
Kinking at the graft will cause flow disturbance and lead to thrombus formation and subsequent 
graft failure. Gore-Tex came up with stretch ePTFE grafts with higher degree of conformability 
and resistance to kinking and a study was conducted in 1992 to test the patency of stretch ePTFE 
grafts. Thirty-seven patients were involved in the study where 17 patients received standard small 
diameter ePTFE grafts and the remaining 20 received stretch ePTFE grafts. Two of the standard 
ePTFE grafts were occluded within 24 h of operation and two stretch ePTFE grafts were occluded 
after 2 and 5 months. Although stretch ePTFE grafts have higher patency than standard ePTFE 
grafts, the primary patency of both types after 1 year of implantation are low (59% for stretch 
ePTFE graft and 29% for standard ePTFE graft).13  
Another commonly seen problem in an ePTFE graft is stenosis of the graft lumen at the 
sutured area due to neointima formation which leads to intimal hyperplasia. Neointima is believed 
to be caused by smooth muscle cell proliferation in response to an increase in wall stresses at the 
suture line; the cell proliferation is then followed by angiogenesis into the mass. When the stenosis 
is reaching about 50% of the lumen, an endovascular intervention with angioplasty is usually 
performed to reopen the lumen wider. However, study has documented the recurrence of stenosis 
5 months after the treatment.14  
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1.5 Other synthetic materials for making small diameter vascular grafts 
With the current limitation of small diameter ePTFE vascular grafts, other polymers and 
composite materials were explored including poly(ε-caprolactone) (PCL),4, 15-16 polyurethane 
(PU),17-19 poly(vinyl) alcohol (PVA),20-23 silk fibroin,24-27 poly(ʟ-lactic acid) (PLA).28-33 Moreover, 
existing ePTFE graft was also modified with extracellular matrix protein such as heparin to 
improve its patency rate.34-36 The properties of the vascular graft materials based on the cited 
papers above are summarized in the following table and is compared to the golden standard 
(femoral artery): 
Table 1. Vascular graft material properties for making small diameter graft 
 
Additionally, Thomas et al.37 summarized the ideal vascular graft criteria as follows: 
• Infection-resistant 
• Biocompatible (noninflamatory, nontoxic, noncarcinogenic, nonimmunogenic). 
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• Nonthrombogenic and acquire certain level of porosity to prevent leakage but can serve as 
selective permeable diffusion barrier 
• Capable to match blood vessel mechanical properties (strength, compliance, suture 
retention, burst pressure, kink resistant) 
• Acquire vasoactive physiological properties to allow constriction and relaxation of graft in 
the presence of neural or chemical stimuli 
• Practical in fabrication technique and cost-effective to allow for large scale fabrication in 
order to meet the demand. 
At the current state, none of the vascular graft materials can fully meet all the mentioned 
criteria. However, it is important to note that what considers a critical property in one graft material 
may not be required in other small diameter vascular graft applications as different implantation 
site of the small diameter vascular graft may have different requirement, e.g. graft length and 
mechanical property. Our group is particularly interested in utilizing PVA hydrogel as small 
diameter graft material due to its excellent mechanical property tunability and the ease of its 
fabrication over PU.  
1.6 Polyvinyl alcohol hydrogel properties 
Polyvinyl alcohol (PVA) is a hydrogel material, rich in –OH function group and can be 
produced from base hydrolization of polyvinyl acetate ester function group. The hydrolization 
percentage of PVA determines the polymer chain conformation in solvent such as water because 
–OH function group is hydrophilic while –OCOCH3 function group is hydrophobic. In a fully 
hydrolized PVA where there is no presence of –OCOCH3 function group, the polymer is highly 
soluble in water and has a high packing density. 
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To use PVA for medical application, the polymer has to be first crosslinked in order to 
obtain the desirable mechanical integrity. PVA can be physically crosslinked with freeze-thaw 
method or photo-crosslinking method with UV-radiation in the presence of sensitizer, or 
chemically crosslinked through reaction with its –OH function group with the addition of toxic 
chemical such as glutaraldehyde. Lately, a study has also shown the use of safe food grade 
crosslinker such as sodium trimetaphosphate (STMP) to make crosslinked PVA polymer with 
good mechanical property.20 All of the crosslinked PVA is water-insoluble. 
In freeze-thaw method, PVA solution is cooled to -20oC and thawed back to room 
temperature for a few times. The physical crosslinking of PVA can happen due to the formation 
of crystalline regions during this process. Crosslinked PVA with freeze-thawed method exhibits a 
higher degree of swelling in water.38 However, one disadvantage of crosslinking PVA with freeze-
thaw method is the dissolution of some of the uncrosslinked or weakly crosslinked polymer chain 
into the solvent during swelling.39 Its Young’s modulus is also generally lower than the chemically 
crosslinked PVA.40 
In photo-crosslinking method, the crosslinking of PVA is done with UV-radiation which 
requires the presence of sensitizer such as sodium benzoate. Photolysis of sensitizer provides a 
radical that abstract a tertiary hydrogen atom from the polymer chain, yielding to a polymeric 
radical. This polymeric radical will then react with the –OH groups and form ether bonds between 
the polymer chains.41 
Furthermore, in chemical crosslinking method, glutaraldehyde in alcoholic solution can be 
used to chemically crosslink PVA; generally, in the presence of acid such as HCl or H2SO4. The 
swelling of PVA by the alcoholic solvent promotes the diffusion of glutaraldehyde and protonic 
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ions; the latter catalyzes the crosslinking reaction.42-43 Subsequently, a study in 2008 has shown 
the possibility of creating crosslinked PVA with glutaraldehyde in the absence of acid. This 
reaction is done in 40oC. An increase in glutaraldehyde concentration is known to create more 
branching of the polymer.42  
Also in 2008, Chaouat et al. successfully fabricated crosslinked PVA with food grade 
crosslinker sodium trimetaphosphate in the presence of a strong base sodium hydroxide.20 The 
exact mechanism of this reaction has not been studied; however, our group hypothesizes that 
sodium hydroxide might help to create oxygen radical that subsequently opens the 
trimetaphosphate ring, creating a phosphate bond that links two polymer chains together. 
PVA has also been successfully used in many biomedical applications as summarized in 
Table 2 below.  
Table 2. Biomedical applications of PVA hydrogel material 
Crosslinking method Application References 
Freeze-thaw pH sensitive membranes for Theophylline drug delivery Nugent et al.38 
 Bioprosthetic heart valve stent Wan et al.44 
 Heart patch for basic-fibroblast growth factor delivery Fathi et al.45 
 Artificial knee meniscus for osteoarthrosis patient Kobayashi et al.46 
Electron beam Soft contact lens Yang et al.47 
Chemical Multilayered hydrogel film system for insulin delivery Ding et al.48 
 Vascular graft Chaouat et al.20 
  Cutiongco et al.21-22 
Some of these works have reached pre-clinical study stage (in vivo implantation in animals) and 
one of the study reported minimal the inflammatory reaction minimal with moderate fibrous host 
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tissue response around the scaffold,45 while the other did not observe any significant inflammatory 
reaction, indicating the biocompatibility of PVA.46 
1.7 The current state of small diameter PVA vascular graft 
The suitability of PVA for making a small diameter vascular graft is determined by its 
property. Firstly, PVA is non-toxic, non-immunogenic, non-carcinogenic, and highly 
biocompatible. PVA is highly hydrophilic and without any addition of biomolecules or any 
bulk/surface modifications, PVA is biologically inert. Therefore, it is non-platelet activating or 
non-thrombogenic as shown previously by our group with an in vitro study using platelet rich 
plasma incubation and scanning electron microscopy method to assess the platelet shape on PVA 
surface.21  PVA flexibility can range from 0.7 MPa49 to 46 GPa50 depending on the crosslinking 
method and the degree of crosslinking between the polymer chains. The wide range of Young’s 
modulus allows PVA to be made flexible enough to match the stiffness of native blood vessel. 
Study has also shown that PVA has decent burst pressure and suture retention strength to withstand 
pulsatile flow in vivo.20  
A study of small diameter STMP crosslinked PVA vascular graft (2 mm diameter) was 
first published in 2008. The graft was made from crosslinked PVA film which was wrapped around 
a PTFE rod and was either glued or sutured to connect the two edges to create a tube.20 The small 
diameter grafts were implanted in rat aorta with end-to-end anastomosis and maintained their 
patency after 1 day and 7 days of implant. Continuing from this study, our group fabricated PVA 
grafts with dip casting method and performed in vitro cell study of patterned PVA films as well as 
in vivo study of 2 mm diameter PVA grafts with surface topography in rat aorta.  What we found 
from the in vitro cell study was that the attachment of endothelial cells on patterned PVA surfaces 
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with 2x2x2 µm gratings and 1.8 µm concave lenses topography was significantly improved 
compared to unpatterned PVA, although the endothelial monolayer can be achieved only on N2 
plasma treated PVA films after 6 days in culture. On these substrates also, the contact angle was 
measured and we observed that 2 µm gratings and 1.8 µm concave lenses has significantly higher 
contact angle compared to the unpatterned PVA control which means that the apparent surface 
wettability of these substrates have changed and resulted in an improved endothelialisation in vitro. 
Furthermore, the implanted grafts were implanted with end-to-end anastomosis for 20 days in the 
rat model. Both PVA grafts with 1.8 µm convex lenses topography and unpatterned surface were 
occluded, while 2 µm gratings, 2 µm pillars, and 1.8 µm concave lenses show partial graft patency 
after 20 days. In another in vivo study with a rabbit model, our group has also implanted 
submillimeter PVA grafts (0.9 to 1 mm diameter) with unpatterned surfaces at rabbit femoral artery 
and achieved 14- to 17-day patency rate of 67%.  
1.8 Limitations of small diameter PVA grafts and hypotheses 
Despite the excellent mechanical property tunability, PVA material requires surface 
modification to improve graft endothelialisation and, at the end of the day, graft patency. From the 
previous in vitro cell adhesion study, N2 plasma modification seemed to improve endothelial cell 
attachment of PVA films.23 However, to utilize this surface modification for a vascular graft, 
luminal plasma treatment is required instead. Mantovani et al. has previously shown a technique 
to plasma treat ePTFE graft lumen of 10 mm inner diameter with NH3 plasma.
51 However, on 




The implanted PVA grafts in rat and rabbit model were all sterilized with γ-radiation. 
However, there are more than one options to terminally sterilized a hydrogel material. Some 
studies have shown the effect of EtO and γ-radiation terminal sterilization on material and 
mechanical property of polymer other than chemically crosslinked PVA.52-53 Because the 
sterilization step can create changes on the material, studying the effect of it on graft mechanical 
property and endothelialisation is important and has never been explored before.  
Achieving 67% patency rate over 15-17 days of submillimeter PVA graft implantation in 
rabbit femoral artery is commendable. However, the implantation was done with end-to-end 
anastomoses as in other small diameter synthetic vascular graft studies; while end-to-side 
anastomosis is a more clinically relevant method. It was not known whether by changing the 
anastomoses method, graft endothelialisation will be affected given the change in hemodynamic 
and longer graft length; and furthermore if the graft can remain patent when the implant duration 
is increased to 28 to 30 days.  
In this thesis, we hypothesize that in vitro and in vivo endothelialisation of small diameter 
PVA grafts can be enhanced by the luminal surface modification method and will not be affected 
by graft sterilization process. Specifically, we hypothesize that the effect of this plasma 
modification in combination with the microtopography would enhance endothelialisation further 
without invoking severe platelet activation reaction. We also speculate that γ-radiation minimally 
changes graft mechanical property and that it has minimum toxicity which could affect surface 
endothelialisation. Lastly, we hypothesize that PVA grafts will maintain its patency at 28 to 30 
days of implant.  
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1.9 Research scope and thesis outline 
The research focus of this thesis can be outlined into 3 main aims which correspond to chapter 
2, 3, and 4 of this thesis: 
(a) Aim 1: Luminal modification of small diameter PVA vascular graft 
PVA hydrophilicity makes its surface unfavorable for cell attachment; while endothelialisation of 
a graft lumen can help to prevent thrombus and IH formation. Hence, surface modification of the 
PVA graft is necessary to improve endothelial cell attachment. Specifically, in vitro cell adhesion 
study with human umbilical vein endothelial cell line, EA.hy926 on the modified and unmodified 
PVA graft will be reported. This consists of surface characterization of the modified PVA surfaces, 
and quantification of cell number and endothelial cell gene and markers expression. In addition, 
platelet activation test result of the modified PVA graft will be reported as alteration of surface 
property (preferring cell attachment) could increase platelet activation level. 
(b) Aim 2: Effect of terminal sterilisation on PVA graft and endothelialisation  
Prior to implantation to an animal model, it is necessary to sterilize PVA grafts. An ideal 
sterilization method should maintain graft mechanical, physical, and chemical property while 
being effective in inactivating microorganism. The effect of two terminal sterilization method, EtO 
and γ-radiation will be investigated. Specifically, changes in mechanical and material properties 
will be reported. Mechanical properties include radial compliance, minimum bend radius, burst 
pressure, suture retention strength, and Young’s modulus, while material property include FTIR 
spectra, crystallinity degree, XPS, and water contact angle. In addition, changes in 
endothelialisation of PVA and surface topography and contact angle will be reported. 
(c) Aim 3: In vivo study of PVA vascular grafts 
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In vivo study using a relevant animal model is needed to prove graft safety, efficacy, and patency 
in order to better achieve a success in clinical trial. Rabbit is chosen as a suitable animal model to 
test our small diameter PVA vascular grafts. Specifically, successful PVA graft implantation in 
end-to-side configuration and patency rate assessment will be reported. Graft patency and 
endothelialisation will be assessed based on ultrasound flow measurement and histology. 












The expression of cell adhesion molecules (CAM) on cells surfaces affects the ability of 
cells to interact with their surrounding environment. The higher expression of CAM creates larger 
contact area and affinity to a material surface. Given this fact, cell attachment and interaction with 
its surrounding is an active phenomenon, unlike the non-living colloidal system in general.54 The 
non-specific binding due to Van der Waals forces may hence be superseded by the short range 
specific interaction called the ligand-receptor binding.54 This specific interaction is highly 
dependent on spatial organization of the binding site at the receptor and the interaction is sequence 
specific.55-56 
In particular, cells- material interaction is facilitated by cell membrane receptors called 
integrins which are collectively known as focal adhesion.57 Each integrin has a specific ligand type 
which helps a cell to anchor onto material surface. The configuration of ligands on surface material 
can also promote other cell responses including cell migration,58 cell alignment59 and cell 
differentiation.60 Therefore, the improvement of cell adhesion on a material surface can be 
achieved by providing ligands to the integrin which can be done through adding certain function 
groups (amine, amide, or carbonyl) on the biomaterial surface or through improving protein/ ligand 
immobilization on the material surface by hydrophobic interaction. 
One of the well-recognized techniques to promote cell adhesion on a material surface is 
through plasma treatment. Plasma is an ionized gas consisting of free electrons and positive ions 
which make it highly conducting. The chemistry of plasma affects the type of functional group 
that is formed on the surface; this functional group facilitates the interaction between proteins and 
biomaterial surface. For example, silanol group (polar) is formed when treating polydimethyl 
siloxane (PDMS) with oxygen plasma,61 while carboxyl, hydroxyl, vinyl and thiol functional 
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groups can be created by treating the material surface with CO2, hydrogen, oxygen, hydrogen 
sulfide plasma, respectively. The H2/N2 plasma treatment has been known to have the capability 
to surface functionalize flat PVA film surface via the introduction of amide, carboxylic acid, and 
OH/NH function groups.62 This result was confirmed through FTIR spectra which reveal the new 
peaks appearance at 1654 cm-1, 1705 cm-1, and 3200-3400 cm-1 respectively. The use of plasma 
treatment to modify a lumen of a tubular structure, however, has not been widely employed. 
Mantovani et al. has successfully developed a luminal NH3 plasma treatment system to 
treat ePTFE vascular graft of length 20-150 mm long and ID 10 mm wide.51 With the similar set 
up, herein, the result of a more challenging NH3 plasma modification for a small diameter vascular 
graft (≤ 6 mm internal diameter (ID)) will be reported. 
Alteration of apparent surface hydrophilicity can also be done through introducing 
microtopography on the graft luminal surface. However, due to the high aqueous content of PVA 
hydrogel, it is difficult to perform traditional lithography techniques to create micropatterns on 
PVA. Moreover, performing photolithography on hydrogel could result in the generation of 
cytotoxic photoinitiators.63-64 Our group has previously reported that using a simple casting method 
and ultrasonication, we are able to pattern PVA graft lumen with good fidelity.23 Herein, by 
employing the same fabrication method, two selected microtopographies which have been shown 
to improve endothelial cell attachment will be fabricated. These topographies are 2x2x2 µm 
gratings and 1.8 µm concave lenses. As any alteration in surface property can also change platelet 
response to the biomaterial surface, the modified small diameter PVA grafts will also be tested for 
platelet activation and fibrin deposition by using ex vivo shunt model as reported previously.65  
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In this chapter, we are looking into the effect of luminal NH3 plasma treatment together 
with the selected microtopographies on the attachment of human umbilical vein endothelial cell 
line (EA.hy926) on the PVA small diameter vascular graft and on the platelet activation with ex 
vivo shunt model. We hypothesize that: (1) NH3 plasma alone can enhance endothelial cell 
attachment on PVA surface, (2) combination of surface topography and plasma modification 
improves further endothelial cell attachment on PVA surface, and (3) plasma modification 
minimally affects platelet activation. 
2.2 Materials and Methods 
2.2.1 PVA graft fabrication 
The steps for crosslinking PVA with sodium trimetaphosphate (STMP) is prepared 
according to Chaouat et al.20 In brief, 10% (w/v) PVA (Aldrich, Mw 85,000-124,000, hydrolysis 
percentage 87-89%) was mixed with 15% (w/v) STMP (Aldrich) for 5-10 minutes until 
homogeneous solution is obtained. Afterwards, 30% (w/v) NaOH (Sigma-Aldrich) was added into 
stirring solution and the solution was mixed for another 5-10 minutes. The solution was then 
centrifuged to remove any bubbles. 
A cylindrical rod coated with crosslinking PDMS (base : crosslinker = 10:1) (Dow 
Corning, Sylgard 184) was cured at 60oC. The PDMS coated needle was air plasma treated (85W, 
0.8 NL/h) for 80 seconds and was coated with layers of crosslinking PVA solution. Coated 
cylindrical rod was then kept in a cabinet with controlled temperature of 20oC and controlled 
humidity of 70% for 3 days. Afterwards, PVA coated cylindrical mold can be rehydrated in 




Figure 1. Schematic diagram of polyvinyl alcohol (PVA) graft fabrication with dip casting method, 
adapted from Cutiongco et al.23 Reproduced with permission from Elsevier. 
2.2.2 PVA film fabrication 
Similar to the aforementioned method, 10% (w/v) PVA was mixed with 15% (w/v) STMP 
for 5-10 minutes until homogeneous solution is obtained. Afterwards, 30% (w/v) NaOH was added 
into stirring solution and the solution was mixed for another 5-10 minutes. The solution was then 
centrifuged to remove any bubbles and was poured into dishes. The dishes were kept in a cabinet 
with controlled temperature of 20oC and controlled humidity of 70% until the PVA film is 
completely dried. Afterwards, PVA film can be rehydrated in deionized water and demolded from 
the dishes. 
2.2.3 Patterned PVA graft fabrication 
The preparation of crosslinking PVA solution is as mentioned above. A thin layer of 
micropatterned PDMS was made by spin coating of 2g of crosslinking PDMS (base : crosslinker 
= 5:1) on a patterned PDMS mold at 1500 rpm for 15 seconds. Afterwards, the thin PDMS layer 
was rolled around the cylindrical rod and was air plasma treated as before. The rod was kept in 
crosslinking PVA solution and was sonicated for at least 90 minutes at 49 kHz. The cylindrical 
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rod was then coated with layers of crosslinking PVA and it was kept in a cabinet as before. The 
rehydration of the PVA patterned tubes was done in 10x Phosphate buffered saline (PBS) (Fisher 
Scientific) followed by 1x PBS and deionized water.  
2.2.4 Patterned PVA film fabrication  
The preparation of crosslinking PVA solution is as mentioned above. Crosslinking PVA 
solution was poured on a dish with PDMS patterned mold. The dish was centrifuged at 600 rpm 
for 1.5 hours and was kept in a cabinet with controlled temperature and humidity as before until 
PVA film was fully dried. The rehydration of patterned PVA film was done in 10x PBS followed 
by 1x PBS and deionized water. 
2.2.5 Scanning electron microscopy 
PVA was dehydrated and coated with gold nanoparticle. Scanning electron microscope 
images were taken with a high-resolution field-emission scanning electron microscope (Zeiss 
1550, Carl Zeiss AG, Oberkochen, Germany) at accelerated voltage of 7 keV.  
2.2.6 Luminal NH3 Plasma Treatment 
Luminal NH3 plasma treatment with RFGD treatment system was performed as previously 
described.51 In brief, a dehydrated PVA graft was inserted into a cylindrical Pyrex glass tube. Three 
capacitively coupled copper electrodes were located at the middle section of the tube for plasma 
generation. After pressure of less than 5x10-5 Torr was reached, high purity NH3 gas was 
introduced into the chamber from the inlet which was 5 cm below the upper end of the tube. The 
NH3 plasma ignition was initiated by a radio-frequency generator thereafter and modified the 
luminal surface of the PVA graft. 
22 
 
2.2.7 X-ray photoelectron spectroscopy (XPS) measurement 
 The chemical composition of the surface was investigated by XPS PHI 5600-ci 
spectrometer (Physical Electronics, Eden Prairie, MN). The main XPS chamber was maintained 
at a base pressure of < 8x10-9 Torr. An achromatic aluminium X-ray source (1486.6 eV) was used 
at 300W with a neutralizer to record the survey spectra, and a standard magnesium X-ray source 
(1253.6 eV eV) was used to record high resolution spectra of C1s, without charge neutralization. 
The detection angle was set at 45o with respect to the normal of the surface and the analyzed area 
was 0.125 mm2. Measurement was done at 11 equidistant positions along a 5.5 cm long dehydrated 
PVA graft.  
2.2.8 Water contact angle measurement 
 Water contact angle was measured on sterilized and non-sterilized PVA films using an in-
house built instrument. PVA films were hydrated during the test and its surface was dabbed dry 
prior to test. The water volume used for measurement is 3 µl and images were captured within 10 
seconds after the water drop was on the film surface. 
2.2.9 EA.hy926 adhesion study on PVA luminal surfaces 
Unpatterned (UP) PVA tube and two other types of topographies were used in this study: 
2 µm gratings (2µG), and 1.8 µm concave lenses (CCL) tubes. Plasma treated tubes were indicated 
with a letter P behind the abbreviation, i.e. UPP, 2 µGP, CCLP for plasma treated unpatterned, 2 
µm gratings, and 1.8 µm concave lenses tubes, respectively. PVA tube was cut open longitudinally 
and sterilized with UV for 20 minutes, followed by incubation with 10% Penicillin/Streptomycin 
(Gibco) and 1% Amphotericin-B (VWR). PVA was then fixed in a 24-well plate with autoclaved 
silastic tubings using sterilized forceps and was rinsed thoroughly with 1x PBS. Afterwards, PVA 
was incubated with fetal bovine serum (FBS) (Gibco) followed by centrifugation at 1000 rpm for 
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30 minutes. PVA can be kept in 2-8oC fridge overnight or in 37oC incubator for 30 minutes prior 
to cell seeding. 
EA.hy926 (ATCC) cell passage number used in this study is passage number 7. EA.hy926 
culture was done according to ATCC protocol. Confluent cells were passaged with 0.05% 
Trypsin/EDTA (Gibco) and were seeded on the PVA at seeding density 50,000 cells/cm2. The well 
plate was then spun down at 100xg for 10 minutes to bring the cells down closer to the PVA 
substrate. Cells were cultured for 13 days before performing subsequent cell analysis (section 2.2.8 
to 2.2.10). 
2.2.10 Cell number quantification 
Quantifications of cell number on PVA samples were done with CyQUANT® Cell 
Proliferation Assay Kit (Invitrogen) as per manufacturer protocol. In brief, after being in culture 
for 13 days, cells were passaged and collected into microcentrifuge tubes. Cell suspension was 
then spun down at 1500 rpm for 5 minutes and followed by washing of the cell pellet in 1xPBS to 
minimize the interference of phenol red to the intensity reading. Fluorescence measurement was 
done at 530 nm wavelength and the measured values were translated into cell number by using a 
standard curve equation: 𝑛 = 4.086 ∗ 𝐼 + 151.15 , where n is the cell number and I is the 
fluorescence intensity. R2 value of this equation is 0.9976 
2.2.11 Gene expression quantification 
 Quantifications of platelet endothelial cell adhesion molecule 1 (PECAM1) and endothelial 
nitric oxide synthase (NOS3) gene expression were done with RT-qPCR and normalized to the 
18s ribosomal RNA (18s rRNA) as the endogenous control. Forward and reverse primer sequences 
are as published before66 for PECAM1 (forward: 5’-AACAGTGTTGACATGAAGAGCC-3’, 
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reverse: 5’-TGTAAAACAGCACGTCATCCT-3’), NOS3 (forward: 5’-
TGATGGCGAAGCGAGTGAAG-3’, reverse: 5’-ACTCATCCATACACAGGACCC-3’), and 
18s rRNA (forward: 5’-GGCCCTGTAATTGGAATGAGTC-3’, reverse: 5’-
CCAAGATCCAACTACGAGCTT-3’) (Sigma, EasyTM Oligos). RNA isolation was performed 
with RNeasy® Mini Kit (Qiagen) according to the manufacturer protocol. cDNA strand was then 
synthesized using SuperScript® III First-Strand Synthesis System (Invitrogen) according to the 
manufacturer protocol. Lastly, amplification of gene specific region was done using SsoFastTM 
EvaGreen® Supermix with Low Rox (Bio-Rad) also according to the manufacturer protocol. 
Measurements were run in triplicates for each of the experimental groups. 
2.2.12 Cell immunofluorescence staining 
 To prevent the disruption of cell-cell junction, culture was washed with DPBS buffer (1x) 
(Gibco) prior to fixation with 4% paraformaldehyde (PFA) (Sigma Aldrich) for 15 minutes. Cells 
were permeabilized by incubation with 0.05% Triton X-100 (Sigma) and 50 nM glycine (Aldrich) 
for 15-20 minutes. Cell nuclei and F-actin staining was done with DAPI (1:5000) and Phalloidin 
(1:500) (Invitrogen) incubation for 30 minutes respectively.    
2.2.13 Cell image acquisition and analysis 
Cells were imaged using Zeiss immunofluorescence microscope at 20x magnification. 
Images were taken at random positions on the PVA surface and the most representative images 
were selected for brightness and contrast adjustment using ImageJ software. 
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2.2.14 Baboon ex vivo shunt study 
All baboons (Papio anubis) were housed and taken care of by Oregon National Primate 
Research Center (ONPRC) according to “Guide to the Care and Use of Laboratory Animals” and 
is approved by ONPRC Institutional Animal Care and Use Committee.  
The ex vivo shunt study was done by our collaborator, Dr. Deirdre Anderson at 
OHSU/ONPRC. Prior to experiment, baboon platelets were labeled with 111-Indium and 
homologous fibrinogen was labeled with 125-Iodine. Baboon femoral artery and vein were 
accessed and extended with silicon tubing where the PVA graft was attached to for 60 minutes 
without anticoagulant or anti-platelet administration. Afterwards, graft was flushed and fixed with 
10% PFA for platelet and fibrinogen quantification. 
2.2.15 Statistical analysis 
Statistical comparisons between experimental groups were done using one-way ANOVA 
and Tukey’s post-hoc analysis unless otherwise stated in the figure legend. Data were presented 
as mean ± standard error. * denotes statistical significance with p-value of less than 0.05, ** p-
value ≤ 0.01, *** p-value ≤ 0.001, and **** p-value ≤ 0.0001, all is with 95% confidence level. 
Sample size will be reported in the individual figure legend. 
2.3 Results  
2.3.1 Micro patterns on PVA luminal surface show good fidelity  
PVA tubes with 2 µm gratings and 1.8 µm concave lenses topography used for the in vitro 




Figure 2. SEM images of PVA luminal surface patterned with (A) 2 µm gratings and (B) 1.8 µm 
concave lenses topography. 
2.3.2 Increase in nitrogen percentage on plasma treated PVA luminal surface 
 An increase in nitrogen percentage on the plasma treated PVA surface was observed, 
indicating successful introduction of N species on the PVA surface (Figure 3). The %N along the 
plasma treated PVA luminal surface, measured at 11 equidistant positions, averaged at 9.4% while 
on PVA luminal surface without plasma, there was no nitrogen element detected. 
 
Figure 3. XPS measurement of PVA luminal surface without plasma (n=3) and after NH3 plasma 
treatment (n=3) measured at 11 equidistant positions along the 5.5 cm-long tube. All data were 
presented as mean ± standard error. 
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2.3.3 Water contact angle measurement reveals higher hydrophobicity on plasma treated 
PVA surfaces 
 Water contact angle of the all plasma treated PVA surface for all topographies 
(unpatterned, 2 µm gratings, 1.8 µm concave lenses) was found to be higher than the untreated 
PVA group (Table 3). Contact angle on untreated 1.8 µm concave lenses topography was unable 
to be measured as it is very close to 0o. Statistical significance was found between the contact angle 
of plasma treated unpatterned PVA surfaces and plasma treated 1.8 µm concave lenses PVA 
surfaces (p ≤ 0.05, n=6). 
Table 3. Water contact angle measurement of PVA surface without plasma and with NH3 plasma. 
All data were presented as mean ± standard error, n=6. 
 Unpatterned 2 µm gratings 1.8 µm concave lenses 
Without plasma 18.8 ± 1.4o 20.5 ± 3.2o Cannot be measured(a) 
NH3 plasma 30.5 ± 6.0
o 26.3 ± 5.2o 14.5 ± 2.0o 
(a) Contact angle was close to 0o 
2.3.2 Improvement of cell adhesion on modified PVA graft luminal surface 
Among the three different topographical surfaces, 2 µm gratings topography consistently 
supported better endothelial cell attachment (Figure 4B, E). The best cell attachment was, however, 
found on the NH3 plasma treated 2 µm gratings PVA tube, forming an endothelial monolayer on 
the PVA luminal surface (Figure 4E). On all topographies, the cells morphology is mostly rounded 
with a better cell alignment observed on the untreated 2 µm gratings rather than the plasma treated 
2 µm gratings. Cells on 1.8 µm concave lenses, with and without NH3 plasma, show the second-
best attachment with random orientation, followed by the unpatterned PVA tube. The cell number 
quantification (Figure 4H) shows that NH3 luminal plasma treatment improves the endothelial cell 
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attachment on the PVA; however, the differences between attachment on PVA surfaces are not 
statistically significant (n=3).  
 
Figure 4. EA.hy926 cell attachment on PVA surfaces without plasma treatment (A-C) and with 
NH3 plasma treatment (D-F) on unpatterned (A, D), 2 µm gratings (B, E), and 1.8 µm concave 
lenses topography (C, F) after 13 days in culture. Orange arrows indicate the gratings direction of 
2 µm gratings topography. Endothelial monolayer formation was observed on plasma treated 2 µm 
gratings topography (E) and on cover slip control (G). Nuclei are shown in blue and F-actins are 
shown in green. Scale bars in all figures are 50 µm. (H) Cell number quantification on PVA 
surfaces with different luminal modifications (UP = unpatterned, 2uG = 2 µm gratings, CCL = 1.8 
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µm concave lenses, UPP = unpatterned with plasma, 2uG = 2 µm gratings with plasma, CCLP = 
1.8 µm concave lenses with plasma) indicates higher cell number on plasma treated PVA surfaces. 
However, no statistical significance was found (n=3). 
2.3.3 PECAM1 and NOS3 genes were upregulated and downregulated on PVA surfaces 
without and with plasma modification, respectively  
 PECAM1 and NOS3 genes were selected among other endothelial cell genes because the 
protein expression of PECAM1 was known to involve in cell-cell junctions, whereas the protein 
expression of NOS3 was known to involve in important endothelial functions of vasodilation, 
platelet inhibition, and anti-thrombogenic agent. The upregulation and downregulation of both 
PECAM1 and NOS3 genes show similar trend (Figure 5). Both genes are upregulated in cells that 
were grown on 2 µm gratings and 1.8 µm concave lenses topography without NH3 plasma 
modification. Interestingly, the expression of PECAM1 and NOS3 genes were both downregulated 
in all plasma treated surfaces. Significant PECAM1 gene downregulation was especially observed 
on the plasma treated 1.8 µm concave lenses topography; the difference of PECAM1 expression 
in 1.8 µm concave lenses topography with and without plasma treatment was highly significant (p 




Figure 5. Relative quantitative expression of endothelial cell genes: (A) PECAM1 and (B) NOS3 
to the respective expression on unpatterned PVA substrate (UP). PECAM1 gene upregulation on 
1.8 µm concave lenses topography without plasma was 1.6-fold higher than the unpatterned PVA 
substrate, while NOS3 was 1.7-fold higher. In general, both genes were upregulated on untreated 
PVA surfaces, while they were downregulated on NH3 plasma treated surfaces. * denotes 
statistical significance with p-value of less than 0.05, ** p-value ≤ 0.01, and *** p-value ≤ 0.001, 
n=3. 
2.3.4 Ex vivo shunt studies show higher platelet and fibrin accumulation on plasma treated 
concave lenses PVA tubes 
 Platelet accumulation was measured every minute over one-hour duration of study (Figure 
6). The highest platelet accumulation occurred on the collagen coated tube which serves as a 
positive control. Interestingly, plasma treated PVA tube with 1.8 µm concave lenses topography 
shows high platelet accumulation with higher mean compares to ePTFE graft. However, there 
difference in mean was not statistically significant. Platelet accumulation on the plasma treated 1.8 
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µm concave lenses topography was, however, found to be significantly higher than the 
accumulation on plasma treated 2 µm gratings topography (p ≤ 0.05, n=6). Moreover, the 
unpatterned plasma treated PVA tube has low platelet accumulation and was comparable to the 
untreated PVA tubes with or without patterns.  
 
Figure 6. Platelet accumulation measurement with ex vivo shunt model. Statistical analysis 
performed with repeated measures ANOVA on 5 minutes timepoint data. Experimental groups are 
categorized into A, B, and C based on their statistical similarities. P-value between different 
statistical group is ≤ 0.05, n=6. 
This result agrees with the fibrin accumulation data which was collected after complete 
decay of Indium-111, where plasma treated 1.8 µm concave lenses tube show the highest fibrin 
accumulation and was comparable to collagen coated positive control (Figure 7). On the PVA 
samples, both plasma-treated and non-plasma treated tube follow the same trend whereby the 1.8 
µm concave lenses tube shows the highest fibrin accumulation, followed by 2 µm gratings and the 
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unpatterned tubes. The difference in fibrin accumulation between unpatterned tubes (with or 
without NH3 plasma) and the plasma treated 1.8 µm concave lenses tubes was statistically 
significant (p ≤ 0.05, n=6). 
 
Figure 7. Normalized fibrin accumulation amount at the end of ex vivo shunt runs. Statistical 
analysis was performed with 2-way ANOVA. * denotes statistical significance with p-value ≤ 
0.05, n=6. 
2.4 Discussions 
In this study, PVA tube luminal surface was treated with NH3 plasma which introduces N 
species to the PVA surface and facilitates specific interaction between PVA surface and 
endothelial CAMs through receptor-ligand binding. Moreover, the presence of surface topography 
is useful in altering PVA apparent hydrophilicity which in turn promote hydrophobic interaction 
with extracellular matrix proteins present in the serum (from initial sample incubation) as well as 
in culture media. The modification of –OH function group as well as alteration in hydrophilicity 
act synergistically to promote endothelialisation of the PVA material. Moreover, topography 
isotropicity as in the case of 2 µm gratings topography helps to improve cell elongation and 
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alignment by providing guidance to the focal adhesions. In the case of adherent cell type like 
endothelial cells, good cell anchorage and spreading allows F-actin stress fibers to form and help 
in the subsequent cell functions.67  
To detect the presence of N species on the PVA surface after plasma modification, XPS 
measurement was performed. An increase in %N element on the plasma treated PVA surface was 
observed, while on the surface without plasma, there was no %N detected. The change in surface 
property was further characterized by measuring water contact angle of the PVA surface. As 
observed previously,23 the presence of N species on PVA surface create a more hydrophobic 
surface property; the trend is consistent across different topographies. Meanwhile, the presence of 
topography increases exposed surface area to plasma modification. Better cell attachment on 2 µm 
gratings and 1.8 µm concave lenses topography compares to the unpatterned PVA group was, 
therefore, expected and can be observed from Figure 4. Interestingly, cell alignment was observed 
more clearly on 2 µm gratings topography without plasma which suggests that on this substrate, 
cells were given more space to sense their underlying topography before they come in contact with 
one another.   
PECAM1 gene involves in the expression of CD31 adhesion molecule at the endothelial 
cell-cell junction. Meanwhile, NOS3 gene is one of the phenotypic genes in endothelial cells and 
it involves in various EC functions.66 Endothelial nitric oxide synthase (eNOS), an endothelial 
marker expression of NOS3 gene, is responsible in the production of nitric oxide (NO) which is a 
vasodilator,11 a platelet function inhibitor, and an anti-thrombogenic agent.68 The expressions of 
PECAM1 and NOS3 gene were measured with RT-qPCR and all groups were normalized to 
unpatterned PVA without plasma group. Both genes were observed to be upregulated on the non-
plasma treated PVA surfaces with  both gratings and micro lenses topographies; however, it is 
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interesting to see that on plasma treated surfaces, the expression of these genes were both 
downregulated with plasma treated 1.8 µm lenses topography showing the lowest gene expression. 
The higher expression of PECAM1 gene could mean a higher expression of CD31 proteins on the 
cell surface and a better contact between cells. In the case of the non-plasma treated PVA surfaces, 
the upregulation of PECAM1 could be caused by cell aggregate formation as often found from the 
qualitative observation of EA.hy926 cells on non-plasma treated PVA surfaces. More experiment 
will be needed to confirm this finding and to better compare between samples with adherent 
monolayer. Furthermore, it is possible to validate this finding by immunofluorescence staining to 
check protein expressions; this will be part of our future works.  
Surface modification to favor cell attachment can promote endothelial cell lining in the 
graft lumen which could prevent thrombosis and improve graft patency. However, in the in vivo 
environment, platelet can also attach and be activated to a bioactive surface before endothelial cell 
layer is established. Platelet initiates blood clotting process by aggregating with one another at its 
active conformation. Moreover, fibrin which comes from a different coagulation cascade helps to 
strengthen the structure by attaching to the clot, forming a mesh-like structure. The result of 
baboon ex vivo shunt study shows an increase in the number of activated platelet over the 1-hour 
study. Interestingly, platelet activation on the plasma treated 1.8 µm concave lenses topography 
were significantly higher than the other PVA experimental groups except for the 1.8 µm concave 
lenses topography without plasma. Fibrin accumulation result shows similar trend, but statistical 
significance was found between plasma treated 1.8 µm concave lenses topography tube and the 
unpatterned PVA tubes with and without plasma. Meanwhile, the 2 µm gratings topography show 
similar platelet and fibrin accumulation to the unpatterned samples with or without plasma 
treatment. This result is consistent with our previous finding with in vitro LDH assay on untreated 
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PVA films with gratings and lenses topography.21 We speculate that 1.8 µm lenses topography is 
a more favorable surface for platelet activation due to its anisotropicity and small gap between 
lenses. The degree of platelet activations of the other PVA groups were still significantly lower 
than the collagen coated glass positive control but show similar or lower platelet and fibrin 
accumulation compares to the ePTFE grafts. 
2.5 Conclusions 
This study has shown the potential of NH3 luminal plasma treatment to improve 
endothelialisation of PVA graft, particularly on 2 µm gratings topography. The PECAM1 and 
NOS3 expression were downregulated on the plasma treated 1.8 µm concave lenses topography 
while the accumulation of activated platelet and fibrin were found to be the highest on this 
substrate. Meanwhile, on 2 µm gratings, the platelet and fibrin accumulation were moderate or 
low. Hence, we conclude that NH3 plasma treated 2 µm gratings topography surface is ideal to 














Sterilization is a way to inactivate microorganism such as fungi, spores, and bacteria, and 
biological agents such as enveloped and non-enveloped viruses. An implant that is poorly sterilized 
could result in infectious agent build up and can cause the implant recipient to adopt diseases. 
US Food Drugs and Administration (FDA) requires terminal sterilization step to be 
performed before a medical device can be implanted in a human body; only when terminal 
sterilization is not feasible, aseptic manufacturing technique is required to be performed. A few 
terminal sterilization methods that are FDA approved include steam, dry heat, ethylene oxide 
(EtO), radiation (γ-radiation or electron beam/E-beam). Each of the sterilization methods has its 
own advantages and disadvantages. Table 3 shows the microorganism inactivation ability of each 
of the terminal sterilization methods, adapted from Dai et al.52 
Table 4. Microorganism inactivation ability of the FDA approved sterilization methods, adapted 































































































High √ √ √ √ √ √ √ 
EtO High √ √ √ √ √ √ √ 
Gamma High √ √ √ √ √  √ 




Both steam and dry heat are heat-based sterilization method with good penetrability. In 
particular, steam heat destructs replication components of a microorganism, while dry heat 
eliminates microorganisms through direct heat and oxidation reaction.52 However, both of the 
sterilization methods can cause structural changes and degradation of thermosensitive polymer.69-
70  EtO sterilization effectively supresses metabolism and division of a microorganism or biological 
agents through irreversible alkylation of cellular components.52, 71 However, studies have shown 
that EtO can accelerate polymer degradation and create toxic residual on the implant surface.53, 72-
73 Additionally, EtO was also found to increase crystallinity of poly(lactic acid) fiber scaffold and 
reduce the overall scaffold size.70 Gamma and electron beam radiation methods offer a promising 
hydrogel sterilizing capability in that they sterilize at a relatively lower temperature and in a shorter 
duration. Also, these radiation methods are known to have high penetration, an ability to break 
down DNA and RNA and to create reactive oxygen species (ROS) that damages cellular 
components.52, 74-75 However, some known drawbacks of the radiation method are that at the 
recommended dose of 25 kGy, radiation can cause scission of polymer chain which may lead to 
softening of polymer mechanical property as well as crosslinking reaction.70, 76-77   
An ideal sterilization method should maintain graft mechanical, physical, and chemical 
property while being effective to inactivate microorganism. To our knowledge, terminal 
sterilization effect on STMP crosslinked PVA has not been investigated before. In this chapter, the 
effect of EtO and γ-radiation to PVA mechanical property, surface chemistry and topography, as 
well as crystallinity will be reported. We hypothesize terminal sterilization could affect the 
mechanical and chemical properties of PVA graft by changing the crystallinity.  
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3.2 Materials and Methods 
3.2.1 PVA vascular graft and film fabrication 
PVA graft and film fabrication and patterning were performed as explained in section 2.2.1 
and 2.2.2. Two-millimeter diameter PVA grafts with different wall thickness were used in the 
sterilization study: PVA_a (0.27 ± 0.05 mm) and PVA_b (0.61 ± 0.06 mm) (see Figure 8).  
 
Figure 8. Cross-sectional view of (A) PVA tubular graft of internal diameter (ID) of 2mm, with 2 
different wall thickness. PVA_a with thinner wall with mean thickness of 0.27mm (0.27 ± 0.05 
mm, n=3) and (B) PVA_b with thicker wall with a mean thickness of 0.61mm (0.61 ± 0.06 mm, 
n=3). 
3.2.2 Sterilization treatment 
Gamma-radiation with dosage of 25 kGy was generated by an annular Co-60 source. 
Irradiation service was provided by Evans laboratory at the University of Toronto. 
Sterilization with ethylene oxide (EtO) gas was performed with the following process 
parameters: preconditioning phase for 90 minutes at 55oC and minimum relative humidity (RH) 
of 70% at puncture, EtO exposure phase for 60 minutes with EtO concentration of 759 mg/L at 
pressure range 400-650 mbar, and aeration phase for 12 hours at 55oC. Sterilization was performed 
at Oregon National Primate Research Center (ONPRC). 
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3.2.3 Mechanical characterization 
3.2.3.1 Compliance test 
For testing of the vascular graft mechanical compliance, a vascular graft of length 3 cm 
with diameter of 2 mm respectively was exposed to intramural pressure 80 mmHg and 120 mmHg. 
The diameter change was captured with stereo microscope with 0.8X magnification and was 
measured using ImageJ software. Compliance was then calculated with the formula: %𝐶𝑟𝑎𝑑 =
𝑑120−𝑑80
𝑑80
× 100% and compliance unit of %/40 mmHg. 
3.2.3.2 Uniaxial tensile test 
Tests were carried out with Universal Mechanical Tester (UMT), 100-kg load cell, cross 
head speed 10 mm/min on a hydrated PVA graft. Gauge length was 1.8 to 2.0 cm. Prior to testing, 
both graft ends were dehydrated to give a better grip; the middle section (2.0 to 2.2 cm long) was 
in hydrated condition when tested.  
3.2.3.3 Bend radius test 
Tests were carried out using series of circles with diameter increment of 1 cm. Graft was 
wrapped around the circles until it reaches the minimum circle radius just before it kinked. The 
graft aspect ratio was 15:1 (length: diameter). 
3.2.3.4 Burst pressure test 
A close-ended graft was exposed to increasing intramural pressure through slow release of 
N2 gas until it reached the maximum pressure it can withstand. Pressure was measured in psi and 
converted into mmHg. (1 psi = 51.71 mmHg) 
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3.2.3.5 Suture retention test 
One throw of polyamide 6 suture (Ethicon, size 8-0 and 6-0 for PVA_a and PVA_b 
respectively) was used. Suture initial position was 3 mm away from the graft end and was tied 
onto a variable load which was increased continually until the graft was ripped. The weight of load 
at the rip was taken as suture retention strength of graft.  
3.2.4 Surface and chemical modification 
3.2.4.1 Fourier-transform Infrared Spectroscopy (FTIR) 
FTIR was done using Bruker Tensor 27 with wavenumber ranges from 500-4000 cm-1. 
3.2.4.2 Scanning Electron Microscopy 
PVA was dehydrated and coated with gold nanoparticle. Scanning electron microscope 
images were taken with a high-resolution field-emission scanning electron microscope (Zeiss 
1550, Carl Zeiss AG, Oberkochen, Germany) at accelerated voltage of 7 keV. 
3.2.4.3 Differential Scanning Calorimetry (DSC) 
DSC was performed using DSC Q2000 (TA Instruments). Heating-cooling cycle was 
performed from 30oC-260oC with ramp 10oC/min using hermatic aluminum pan as reference. Heat 
of fusion was calculated from the second cooling cycle. 
3.2.4.4 X-ray photoelectron spectroscopy (XPS) 
 XPS measurement was performed using unmonochromated Al Kα 1486.6 eV, Thermo VG 
Scientific ESCALab 250 microprobe. The analytical chamber pressure was maintained at 2x10-9 
mbar during measurement. 
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3.2.4.4 Water contact angle measurement 
 Water contact angle was measured on sterilized and non-sterilized PVA films using an in-
house built instrument. PVA films were hydrated during the test and its surface was dabbed dry 
prior to test. The water volume used for measurement is 3 µl and images were captured within 10 
seconds after the water drop was on the film surface. 
3.2.5 Cellular characterization 
3.2.5.1 EA.hy926 cell seeding on sterilized (γ-irradiated) and non-sterilized PVA films 
Unpatterned (UP) PVA films and PVA films with 2 µm gratings topography (2uG) were 
cut in the size of a 24-well plate and were sent in a hydrated state for γ-radiation treatment. The 
films were then sterilized with UV for 20 minutes, followed by incubation with 10% 
Penicillin/Streptomycin and 1% Amphotericin-B for 1 hour at 37oC. PVA was then fixed in a 24-
well plate with autoclaved silastic tubings using sterilized forceps and was rinsed thoroughly with 
1x PBS. Afterwards, PVA was incubated with fetal bovine serum (FBS) followed by centrifugation 
at 1000 rpm for 30 minutes. PVA can be kept in 2-8oC fridge overnight or in 37oC incubator for 
30 minutes prior to cell seeding. 
EA.hy926 (ATCC) cell passage number used in this study is passage number 8. EA.hy926 
culture was done according to ATCC protocol. Confluent cells were passaged with 0.05% 
Trypsin/EDTA and were seeded on the PVA at seeding density 50,000 cells/cm2. The well plate 
was then spun down at 100xg for 10 minutes to bring the cells down closer to the PVA substrate. 





3.2.5.1 Cytotoxicity qualitative assessment 
 For qualitative assessment of the toxicity of γ-irradiated PVA, cells were stained with 
LIVE/DEADTM Cell Imaging Kit (Invitrogen) according to the manufacturer protocol. Prior to 
adding dyes, cell culture media was replaced with HEPES-BSS buffer (Lonza). Culture was 
incubated for 15 minutes at 37oC and washed twice with HEPES-BSS buffer prior to imaging.  
3.2.5.2 Cell number quantification 
Quantification of cell number on PVA samples was done with CyQUANT® Cell 
Proliferation Assay Kit as per manufacturer protocol as mentioned in section 2.2.8. In brief, after 
being in culture for 13 days, cells were passaged and collected into microcentrifuge tubes. Cell 
suspension was then spun down at 1500 rpm for 5 minutes and followed by washing of the cell 
pellet in 1xPBS to minimize the interference of phenol red to the intensity reading. Fluorescence 
measurement was done at 530 nm wavelength and the measured values were translated into cell 
number by using a standard curve equation: 𝑛 = 3.828 ∗ 𝐼 + 769.31 , where n is the cell number 
and I is the fluorescence intensity. R2 value of this equation is 0.8727. 
3.2.6 Statistical analysis 
Statistical comparisons between experimental group were done using one-way ANOVA 
and Tukey’s post-hoc analysis. Data were presented as mean ± standard error. * denotes statistical 
significance with p-value of less than 0.05, ** p-value ≤ 0.01, *** p-value ≤ 0.001, **** p-value 




3.3.1 PVA graft opacity changes after EtO sterilization 
The opacity of PVA grafts appeared to be more translucent after EtO treatment; this change 
was more clearly observed in PVA_a group rather than PVA_b group. However, this phenomenon 
was consistently observed in all EtO sterilized PVA grafts (see Figure 9).  
 
Figure 9. EtO sterilized PVA grafts were more translucent than untreated or gamma irradiated 
groups. This trend was consistently observed with PVA_b being less translucent than PVA_a 
group given the thicker graft wall thickness. 
3.3.2 PVA mechanical properties change more drastically after EtO sterilization compares 
to γ-radiation 
Graft compliance of EtO sterilized PVA significantly decreased as compared to untreated 
PVA control group (p ≤ 0.0001 and p ≤ 0.05 for PVA_a and PVA_b group respectively, n=4); 
while graft compliance of γ-irradiated PVA grafts significantly increased as compared to untreated 
PVA control group (p ≤ 0.0001, n=4 for both PVA_a and PVA_b group, see Figure 10 A, B). The 
Young’s modulus of PVA_a and PVA_b also confirms the observation for PVA graft compliance 
whereby EtO sterilized PVA_a and PVA_b have higher Young’s modulus compares to the control 
untreated group, while γ-irradiated PVA_a and PVA_b have lower Young’s modulus (Figure 10 
C, D). Furthermore, similar trend was observed between PVA_a and PVA_b groups whereby the 
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minimum bend radius value of EtO sterilized grafts were lower than the untreated PVA control 
group (p ≤ 0.05 only for PVA_a group); while the γ-irradiated group minimum bend radii were in 
between untreated PVA control group and the EtO sterilized group with no statistical significance 
(Figure 10 E, F). In addition, burst pressure test of PVA_b group revealed a significant increase in 
burst pressure of the EtO sterilized PVA grafts (p ≤ 0.01, n=4); while there were no significant 
differences found in either PVA_a group or γ-irradiated grafts of PVA_b group (Figure 10 G, H). 
Lastly, higher suture retention strength was observed also in EtO sterilized grafts of PVA_b group 
as compared to the untreated PVA grafts (p ≤ 0.01, n=4). Similar trend was observed in PVA_a 




Figure 10. Changes in mechanical properties of PVA grafts after being sterilized with EtO and γ-
radiation. Mechanical properties tested include: (A-B) compliance, (C-D) Young’s modulus, (E-
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F) minimum bend radius, (G-H) burst pressure, and (I-J) suture retention strength. Comparison of 
mean values with experimental replica, n=4. 
3.3.3 Effect on PVA surface and chemical property 
3.3.3.1 No observable difference on FTIR spectra of sterilized and non-sterilized PVA graft 
surfaces  
FTIR was performed to assess any introduction of new ethoxyl function group on the graft 
surface due to ethoxylation reaction between EtO and –OH function group. From the measurement, 
we observed no new peak formed or loss after the sterilization process as shown in Figure 11. The 
peak intensity was found to be a result of measurement variation. Each sample group was measured 
in triplicate. 
 
Figure 11. FTIR spectra of untreated, EtO, and γ-irradiated PVA grafts confirmed the absence/ 
insignificant presence of ethoxyl function group. No new peak formed or loss. 
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3.3.3.2 DSC curves of sterilized and non-sterilized PVA grafts show increase in PVA 
crystallinity 
A significant increase in heat of fusion of the EtO sterilized grafts was observed (p ≤ 0.05, 
n=3); while there was no significant change in the heat of fusion of γ-irradiated grafts (Figure 12). 
Heat of fusion is calculated from the area under exothermic peak of the second cooling cycle and 
is proportional to material crystallinity. 
 
Figure 12. DSC result of untreated, EtO, and γ-irradiated PVA grafts. A significant increase in 
crystallinity was found in EtO sterilized grafts (p ≤ 0.05, n=3). 
3.3.3.3 Microgratings topography fidelity of sterilized and non-sterilized PVA surfaces was 
maintained 
SEM imaging was performed to assess the fidelity of topography after EtO and γ-
sterilization process. As shown in Figure 13, there was no observable change in surface roughness. 





Figure 13. SEM images of unpatterned and PVA with 2 µm gratings topography after being 
sterilized with EtO and γ-radiation.  
3.3.3.4 A decrease of oxygen percentage on γ-irradiated PVA film surface 
 A change in surface property of γ-irradiated PVA was observed from the XPS measurement 
result whereby the %O on the film surface was decreased compares to the untreated PVA group 
(Figure 14B). Similar trend was observed for the EtO sterilized PVA surfaces with a lesser extent. 
Due to this decrease, %C of both EtO and γ-irradiated PVA were slightly increased (Figure 14A); 




Figure 14. XPS measurement results showing (A) %C and (B) %O on the untreated and sterilized 
PVA surfaces. A significant increase and decrease in %C and %O respectively was observed on 
γ-irradiated PVA surfaces, n=3. * denotes statistical significance with p-value ≤ 0.05, comparison 
was performed against untreated PVA control. 
3.3.3.4 Water contact angle measurement reveals significant change of γ-irradiated PVA 
film surface 
The water contact angle of γ-irradiated PVA film was significantly increased compared to 
the untreated group (Figure 15) (p ≤ 0.05, n=4). In contrast, the water contact angle of EtO 
sterilized PVA film was reduced but no statistical significance was found between the untreated 




Figure 15. (A) Summary of PVA water contact angle and selected water contact angle images for 
(B) untreated PVA, (C) EtO sterilized PVA, and (D) γ-irradiated PVA groups. * represents 
statistical significance with p-value ≤ 0.05, ** p-value ≤ 0.01, n = 4. 
3.3.4 Cellular study shows the non-toxic property of γ-irradiated PVA  
The effect of PVA sterilization step, in particular γ-radiation, on endothelialisation was 
assessed by performing in vitro cell adhesion and toxicity study with EA.hy926. Cellular study 
was done with unpatterned PVA control and 2µm gratings PVA films, both with and without γ-
radiation treatment. On day 14, endothelial monolayer was established on γ-irradiated PVA with 
2µm gratings topography and the cells showed to have a clear alignment along the gratings parallel 
direction (Figure 16). Whereas on unpatterned PVA (with and without γ-radiation treatment) and 
2µm gratings PVA without γ-radiation treatment, cells did not proliferate as fast and have a more 
rounded morphology. The cell number on 2µm gratings topography with γ-radiation treatment is 
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significantly higher than the other three groups, but still significantly lower than the cover slip 
controls (p ≤ 0.0001, n=5) (Figure 14F). Hence, the γ-irradiated PVA surfaces were found to be 
nontoxic and to improve endothelialisation. No cell death was observed on the day of imaging. 
 
Figure 16. Live/dead staining of EA.hy926 cells on (A) unpatterned PVA without γ-radiation, (B) 
unpatterned PVA with γ-radiation, (C) 2 µm gratings PVA without γ-radiation, (D) 2 µm gratings 
PVA with γ-radiation, and (E) cover slip control after 13 days in culture. Orange arrows indicate 
the direction of gratings, scale bar: 50 µm. (F) Cell number quantification using CyQUANT® cell 
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proliferation assay kit showed a significant improvement in the number of adherent cells on 2 µm 
gratings PVA with γ-radiation (2uG-γ) compares to the other experimental groups (unpatterned 
PVA without γ-radiation (UP), 2 µm gratings PVA without γ-radiation (2uG), and unpatterned 
PVA with γ-radiation (UP-γ)). ** represents statistical significance with p-value ≤ 0.01, *** p-
value ≤ 0.001, n=5. 
3.4. Discussions 
PVA grafts compliance was increased after γ-radiation treatment and decreased after EtO 
sterilization. This result is interesting and counter-intuitive as we would expect a more translucent 
graft to be more compliant. Moreover, weaker graft material would result in higher minimum bend 
radius (more easily kinked at higher degree of curvature); hence, the minimum bend radius result 
is in agreement with the compliance test result whereby the EtO sterilized grafts were found to be 
less compliant than the control group. In all the experimental groups, the measured burst pressure 
values were much higher than physiological blood pressure, which means that both sterilization 
method did not detrimentally affect the integrity of our PVA grafts and can be used for in vivo 
study. However, the mechanical property tests confirm that EtO sterilization affects PVA graft 
mechanical property more than γ-radiation and causes it to be stiffer after the treatment; whereas 
γ-radiation does not affect much on the mechanical property of PVA grafts except that it increased 
PVA graft compliance. Further characterization with FTIR was done to look into the presence of 
ethoxyl function group on the EtO sterilized PVA graft as well as to confirm any new peak 
formation or loss due to the sterilization process. Any significant addition of ethoxyl function 
would result in an increase of 2916 cm-1 peak which represents alkane function group. However, 
the FTIR spectra confirmed the absence/ insignificant presence of such function group which 
indicates that the EtO sterilized PVA grafts were safe to be used in vivo without any concern of 
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toxic residual. The interesting phenomenon with regards to the change in EtO sterilized graft 
opacity while at the same time having stiffer mechanical property is well-explained by the DSC 
spectra where an increase in the fractional crystallinity was observed. This change in crystallinity 
coming from EtO sterilization was interestingly observed by other group when sterilizing PLA 
fibers and was speculated to be caused by annealing effect during the sterilization process.70 
As shown in the previous in vitro cell studies (chapter 2 and Cutiongco et al.23),  2 µm 
gratings topography provided the best cell attachment and some cells were even shown to align 
along the gratings direction which mimics the orientation of endothelial cells on the vessel lumen 
in vivo. Hence, understanding the effect of sterilization on the fidelity of 2 µm gratings topography 
is of our particular interest. As shown in Figure 12, the topography was still found to be well-
oriented and this is likely contributed by lesser degree of freedom of the feature; while another 
study showed the disorientation of electrospun ribbons after EtO sterilization step.70 Additionally, 
the aspect ratio of our 2 µm gratings topography is low (width: height = 1:1) and the disruption of 
surface topography may be more prominent in a higher aspect ratio.   
PVA surface property was further characterized with XPS. Interestingly, a decrease in %O 
was observed especially on the γ-irradiated sample. This may indicate that some of the -OH 
function groups on the PVA surface was disrupted due to the radiation, and this finding is further 
supported by the water contact angle measurement of γ-irradiated PVA film (without pattern) 
which was significantly higher (more hydrophobic) compared to the untreated group (Figure 15). 
Since there was no observable change in surface roughness (Figure 13) and FTIR spectra (Figure 
11), we suspect that the effect that γ-radiation has on the PVA graft is more superficial than the 




From the characterization result above, we concluded that γ-radiation is a preferred 
sterilization method for PVA because it has minimal impact to PVA mechanical property and 
crystallinity. The in vitro cellular study was done on γ-irradiated and untreated PVA films, with 
and without 2 µm gratings topography. The significant increase in cell attachment on γ-irradiated 
surface with 2 µm gratings topography was consistently observed in all such samples (n=5). Given 
the water contact angle measurement of unpatterned γ-irradiated PVA surface and a previous water 
contact angle study done by our group on 2 µm gratings topography PVA surface, this could mean 
that the surface hydrophobicity of γ-irradiated 2 µm gratings surface was even higher and thus 
favors the adsorption of extracellular matrix protein which in turn facilitates cell attachment to 
ligands present in the extracellular matrix protein.  
3.4 Conclusions 
Sterilization methods such as EtO and γ-radiation are known to affect polymer mechanical 
integrity. Through this study, we have shown that mechanical compliance of STMP crosslinked 
PVA graft was significantly reduced by EtO sterilization and increased by γ-radiation. Other 
mechanical properties such as bend radius, burst pressure, suture retention strength were not 
greatly affected but showed consistent trend with the mechanical compliance data. Additionally, 
crystallization of EtO treated PVA was shown to be significantly increased. Although the FTIR 
spectra did not show any peak formation and loss, the XPS and water contact angle measurement 
revealed the change in surface property of the sterilized PVA surfaces. It is interesting to see that 
rather having poor cell proliferation on the γ-irradiated PVA due to toxicity, 2 µm gratings 
topography with γ-radiation treatment show a significant cell adhesion and proliferation 
improvement. To conclude, γ-radiation is a more preferred sterilization method for STMP 
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crosslinked PVA graft due to its minute effect on PVA graft mechanical properties and the 













Our group has previously implanted small diameter PVA vascular grafts in rabbit femoral 
artery with the 15-day patency rate of 67%.22 Gamma irradiated grafts with 4 mm length and 0.9 
to 1 mm ID were implanted with end-to-end anastomosis configuration. More importantly in at 
least one of the patent grafts, graft luminal surface endothelialisation was observed. Although this 
result is encouraging, there are still several challenges to nail down. Firstly, an end-to-side 
anastomosis configuration will be a more relevant model for a small diameter bypass vascular graft 
compares to an end-to-end anastomosis configuration. However, implantation of a 2 mm inner 
diameter synthetic vascular graft in end-to-side anastomosis configuration has rarely, if not never, 
been done before. A few studies performing end-to-side anastomosis between two adjacent vessels 
or using a decellularized allograft were reported previously.78-81 However, implantation of 
synthetic vascular graft posts a more challenging problem in that graft and artery thickness do not 
always match which makes it difficult to suture the two in an end-to-side configuration. Secondly, 
endothelialisation of longer graft length would take longer which gives rise to a question of 
whether the graft will remain patent throughout the duration of implant when graft 
endothelialisation does not occur fast enough and thrombogenesis could take place. Thirdly, longer 
implant duration would give an opportunity for the formation of intimal hyperplasia and thrombus 
which again gives rise to the issue of graft patency rate. 
One persistent issue with a small diameter vascular graft is the formation of 
neointima/intimal hyperplasia (IH) at graft anastomoses which causes stenosis and subsequent 
graft failure. There are at least two causes of IH which are widely believed by the cardiovascular 
society. The first cause is the wall shear stress (oscillatory, shear stress gradient) which in most 
cases is unavoidable; for example, the inflexion in bypass vascular graft configuration which cause 
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the blood flow profile to be skewed to the internal side of the graft closer to the native vessel. The 
second cause is vessel injury which results from a mismatch in mechanical compliance between 
graft material and native vessel, creating a high stress region at the suture line when graft and 
vessel is under pulsation. Later studies have also reported the importance of suturing technique to 
the compliance at the anastomosis region which can affect the hemodynamic of blood in and out 
of the vascular graft. Generally, both interrupted and continuous suturing will create a para 
anastomotic hypercompliant zone (PHZ) within 1-4 mm width from the suture line with the latter 
having a greater magnitude of PHZ.82 
To answer the question of whether small diameter PVA vascular graft can stay patent given 
the listed challenges above and to achieve a success in future clinical trial, in vivo studies using 
animal model are necessary.  
The tendency of neointima formation varies between species. Rabbit was chosen among 
other small animal models because its hemodynamic and hemostatic mechanism resembles 
human’s the most.83 In addition, bigger diameter vessel would represent a better model for intimal 
hyperplasia study due to the blood flow and shear stress experienced by the vessel. Hence, rabbit 
carotid artery was chosen as the implant site. The mechanical property of rabbit carotid artery in 
comparison to human brachial artery and PVA graft is shown in Table 4. Human brachial artery is 
chosen as an example of small diameter vessel in the extremities. 
Table 5. Comparison of mechanical properties between PVA graft, rabbit carotid artery and human 
brachial artery 
Properties PVA graft Rabbit carotid artery Human brachial artery 
Internal diameter (mm) ≤1 to 6 1.9 to 2.1 83 3.44 to 4.42 84 
Compliance (%/40 mmHg) 1.5 to 9 3.1 85 1.3 to 3.3 86 
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Young’s modulus (Pa) 2-8 x 105 6.45 x 106 87 1.0 x 105 88 
Suture retention (g) 83 to 200 Not available Not available 
 Having all the challenges and literature studies in mind, we hypothesize that a longer small 
diameter PVA graft can be implanted in end-to-side anastomosis configuration and maintain its 
patency throughout 28- to 30-day implant duration in rabbit carotid artery. Furthermore, we 
hypothesize that there will be no observable inflammation reaction at the end of implant duration. 
4.2 Materials and Methods 
4.2.1 Animal handling and animal care committee approval 
Vascular graft implants in male New Zealand White rabbits (Oryctolagus cuniculus, 
3.7±0.2kg) were performed at the Center of Animal Facility (CAF) at the University of Waterloo. 
Studies were approved (#AUPP 16-09) by the Animal Care Committee according to the Canadian 
Council on Animal Care’s Guidelines, the requirements of Province of Ontario’s Animals for 
Research Act, and the University of Waterloo’s Guidelines for the Use of Animals in Research 
and Teaching. CAF was accredited by the Ontario Ministry of Agriculture and Food and Rural 
Affairs with accreditation number 0079-01 and was certified by the Canadian Council on Animal 
Care to have a Good Animal Practice. Baytril (enrofloxacin), 10 mg/kg (Bayer) was administered 
intramuscularly as antibiotic 24hrs before surgery. The rabbit was introduced to isoflurane. 
Narketan (ketamine), 35mg/kg (Vetoquinol) and Xylazine (5mg/kg) administered intramuscularly 
was used for anaesthesia. Heparin, 200 IU/kg (Sandoz)  was given intravenously prior to arterial 
clamping.  In the event of vasoconstriction or spasm of the arteries, 5-10mL of warm (37°C), sterile 
saline solution was applied topically on the constricted vessel. If vasodilation was not observed, a 
few drops (0.3-0.5mL) of Papaverine (a vasodilator) were applied topically on the vessel.   
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4.2.2 Anastomosis technique 
Both PVA (ID: 1.8 mm, length: 1.9 cm) and ePTFE (ID: 2 mm, length: 1.9 cm) grafts were 
both pre-cut in oblique manner (45o) to the graft long axis. Rabbit right common carotid artery 
(CCA) was exposed and papaverine (DBL) was applied topically to prevent spasm. Any side 
branches found on the common carotid artery was then ligated. Two vascular clamps of size 3 
were used to clamp the common carotid artery at cranial and caudal positions. To make an end-to-
side anastomosis, a hole was made at the CCA by creating a knot at the vessel wall and then cutting 
away the knotted section. Using 8-0 Ethilon Polyamide 6 suture (Ethicon), the graft was stitched 
onto the vessel with 8-10 interrupted suture knots starting with 1 knot on each cranial (position 1 
in Figure 15B) and caudal side (position 2, 180o apart from position 1) and followed by 3-4 knots 
on each of the lateral and ventral side. After finishing the second end-to-side anastomosis, the mid-
section of the CCA was tied with 2 knots to encourage blood flow through the graft and clamps 
were then released for leak test. 
 
Figure 17. Schematic of (A) bypass graft implant at the common carotid artery with end-to-side 
anastomosis technique and (B) graft cross-section facing the common carotid artery with the order 
and positions of interrupted sutures indicated around the graft. 
62 
 
4.2.3 Ultrasound doppler 
To assess patency of the implanted grafts, ultrasound doppler imaging and measurements 
were done on day 10-17 (midpoint) and on day 28-30 (endpoint). Measurements were performed 
using SonixTouch (Analogic Ultrasound, Peabody) and 10.0 MHz probe. Rabbit was put under 1-
2% isofluorane prior to performing ultrasound measurement. 
4.2.4 Histology of the excised grafts 
Heparin (500 IU) was administered into the blood circulation prior to euthanization with 
sodium pentobarbital (100 mg/kg). The graft, CCA, and surrounding tissues were excised and 
fixed in 4% paraformaldehyde for 72 hours. Tissue was then sectioned according to the dashed 
lines shown in Figure 18. Moreover, tissue embedding was done using Paraplast (Leica) with the 
determined cutting plane facing upwards (see Figure). Tissue slides were stained with standard 
hematoxylin and eosin (H&E) for imaging. To visualize the tissue, 4x and 10x magnification were 
used to get an overall and close up view respectively. 
 
Figure 18. Tissue sectioning map for histology samples. 
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4.3 Results and Discussions 
PVA grafts used in this in vivo study have similar dimension to PVA_a in chapter 3. 
However, to cater for the bypass grafting configuration, PVA grafts were curved at the middle 
section. The compliance value of the low compliance (LC) PVA group was 1.29 ± 0.27%/ 
40mmHg, while the compliance value of the high compliance (HC) PVA group was 1.95 ± 0.62%/ 
40mmHg. The ePTFE grafts (2mm) used in this study have a slightly bigger diameter than the 
PVA grafts (1.8mm). The compliance of these ePTFE grafts was 3.08 ± 1.49%/ 40mmHg. The 
end-to-side anastomosis configuration was successfully done (Figure 19) with interrupted suture 
technique using 8-0 Ethilon Polyamide 6 suture with the suturing order as illustrated in Figure 17. 
The advantage of suturing position 1 and 2 first is to avoid misalignment of graft which potentially 
could cause kinking on the graft. Although the duration in completing one anastomosis is relatively 
longer for an interrupted suturing technique than a continuous suturing technique, interrupted is 
still preferred since continuous suturing technique can produce a purse-string effect and impair 
haemodynamic effect at the anastomosis; it can also exaggerate PHZ.82 Also, another advantage 
of doing interrupted suture is allowing to redo any suture at one position without disrupting other 
sutures. At the endpoint, sutures were found to stay in their original positions. 
 
Figure 19. Day 0 images of PVA grafts (A-B) and ePTFE graft (C) right after surgery. PVA graft 
in (A) has lower compliance and thicker graft wall than in (B). 
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In the study period, 10 rabbits underwent 10 carotid bypass surgeries. All rabbits survived 
until the endpoint (28-30 days). One out of 10 rabbits had an edema after the procedure but 
eventually recovered after getting hot and cold compression for 2 consecutive days. Another rabbit 
was identified to have a slow right eye response and flopped ear after the surgery, but the overall 
being was healthy regardless. Out of the 10 grafts that were implanted, only 9 grafts were analyzed 
because one graft was found in kinked condition at the time of tissue excision and there was no 
blood flowing through it. The 9 grafts that were analyzed consist of 3 low compliance (LC) PVA 
grafts, 4 high compliance (HC) PVA grafts, and 2 ePTFE graft. Two out of 3 LC PVA grafts and 
3 out of 4 HC PVA grafts were partially patent, while 1 out of 2 ePTFE grafts was patent. PVA 
grafts with lower compliance yielded a lower 28- to 30-day patency rate (67%) than PVA grafts 




Figure 20. Ultrasound flow measurement (M-mode) of the PVA grafts (HC and LC) and ePTFE 
graft at midpoint (day 10-17), endpoint (day 28-30), and their corresponding controls, unoperated 
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left common carotid artery (left CCA). Control flow velocity did not change much from midpoint 
measurement to endpoint measurement. 
Ultrasound flow measurement was performed on all the 8 grafts that were implanted at the 
midpoint (day 10 to 17 after surgery) and the endpoint (day 28-30 after surgery) (Figure 19). It is 
important to note that rabbit to rabbit blood flow rate variation, as assessed from the unoperated 
side of the common carotid artery, can be quite substantial even with the similar dose of 
anaesthetics. Hence, for the analysis, we are reporting relative volumetric flow rate, that is, the 
ratio between volumetric flow rate of PVA graft and of the unoperated contralateral control. Seven 
out of 7 PVA grafts and 1 out of 2 ePTFE grafts are still patent at the midpoint ultrasound 
measurement. In 5 out of 7 PVA grafts, a decrease in relative volumetric flow rate from the 
midpoint measurement to the endpoint measurement was observed (see Table 5). The increase in 
volumetric flow rate ratio of rabbit #5 and #6 could be caused by measurement errors. IH or 
thrombus formation could be the main issue causing graft stenosis and flow decrease over time. 
Also, it was apparent in one of the grafts that the stenosis was worse at the distal anastomosis 
rather than proximal as the flow profile showed an increase in flow velocity from proximal to distal 
end (Figure 21). Percent stenosis values in Table 6 were calculated from the cross-section area of 
tissue ingrowth covering the graft lumen; where a 100% stenosis indicates complete obstruction 
to the blood flow by the tissue ingrowth. In the case of rabbit #3, graft was occluded at the endpoint 
due to both tissue ingrowth and thrombus. All values in Table 6 have 3 significant figures. 





(a) Measurement is unable to be done due to unsuccessful tissue sectioning. 
(b) Ultrasound measurement was not done. 
 
Figure 21. Ultrasound measurement of flow velocity versus time shows an increase in magnitude 
from graft inlet to graft outlet. 
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Figure 22 shows the hematoxylin and eosin (H&E) staining of excised vascular graft at 
point 1 or 2 according to tissue sectioning map shown in Figure 18. Based on the H&E staining of 
the tissue sections, there was no observable inflammatory reaction found from any of the excised 
tissues. Interestingly, the anastomoses sections (both distal and proximal) showed that IH was 
formed mainly on the native artery close to the heel and bed regions and not on the PVA graft 
lumen (Figure 22 A, B). The heel and bed regions are expected to be close to one another due to 
the position of vessel ligation (indicated with small x in Figure 17 and 18). Unlike tissue response 
towards PVA grafts, neointima tissue was observed to grow and attach well on the ePTFE grafts 
(Figure 22 E, F, G, H). Furthermore, tissue encapsulation was found around the excised ePTFE 
grafts and was inseparable from the grafts. We suspect that due to animal to animal variation, the 
tissue response on the two implanted ePTFE grafts was different and resulted in one graft being 
patent (Figure 22 E, F), while the other being occluded (Figure 22 G, H). Moreover, in some of 
the PVA samples, thrombus was found attaching on the IH tissue of the native artery, while in 
some others it was observed to be present on the graft lumen (Figure 22 C, D). This thrombus can 
either form during the animal lifetime or post-mortem since tissue excision and fixation happened 
after the animals were euthanized. However, the first could also be one reason for the absence of 
correlation between blood flow rate ratio and graft compliance, while blood flow rate ratio should 
be a good indication of stenosis level at the anastomoses of the grafts. This is also supported by 






Figure 22. H&E staining of anastomoses tissue sections with their respective magnified images of 
the bounded area shown on the right. (A) Patent PVA graft, (B) corresponding magnified view 
shows the presence of intima tissues growing from the native artery, (C) PVA graft with thrombus, 
(D) corresponding magnified view of the thrombus, (E) patent ePTFE graft, (F) corresponding 
magnified view shows the presence of intima tissues on the graft lumen, (G) occluded ePTFE graft, 
(H) corresponding magnified view shows the growth of intima tissues covering graft lumen. Scale 
bar of Figure 21 A, C, E, G is 1 mm, while scale bar of Figure 21 B, D, F, H is 100 µm. 
As for the correlation between PVA graft compliance and IH formation, our preliminary 
observation found that the percent stenosis increased as the graft compliance value increased which 
seems to be contrary to the common belief (see Figure 23). Graft compliance value in this study 
ranges from 1.1±0.5%/40mmHg to 2.8±0.4%/40mmHg, while carotid artery compliance was 
measured with the same in vitro compliance test method and the compliance value was 
2.57±0.04%/40mmHg (n=1), which is close to the compliance value found by another group.88  
One outlier (rabbit #4) was found and was identified to be caused by the angle of implant which 
was much less than 45o angle and caused a more favorable hemodynamic (less wall shear stress) 




















Figure 23. Scatter plot of PVA graft compliance against percent stenosis at distal anastomoses. 
Each point represents one sample and the error bars (SD) were calculated from up to 7 
measurement points along each of the PVA graft sample.  
This preliminary finding prompted us to look into physiological stress factor that could 
affect the artery compliance and the stress-strain profile our PVA grafts. In physiological 
condition, an artery is always under pre-tension; a study on rabbit femoral arteries revealed that 
the pre-tension force that was experienced is 0.113 ± 0.038 N when limb was extended, 0.071 ± 
0.014 N when limb was relaxed.89 Also according to the data found by Fung, et al., the pre-tension 
force places an artery to be at 50% axial stretching, which contributes to the difference in vessel 
compliance in vivo.90 The viscoelasticity of an artery makes it stronger radially as higher force is 
applied longitudinally. In this study, we implanted PVA grafts in end-to-side anastomoses 
configuration; as the grafts are in curved position when implanted, they have more degrees of 
freedom and less pre-tension force. The measurement of graft pre-tension force in vivo is outside 
the scope of this thesis; however, based on the ultrasound flow measurement and histology results, 
we predict that PVA grafts with lower compliance value match better the compliance of rabbit 
common carotid artery in vivo, resulted in higher patency rate; whereas grafts with higher 
(matching) compliance value have higher distensibility than the artery and invoke neointima 
response more severely. Furthermore, Ballyk et al. shows that end-to-side anastomosis of a vein 
graft (higher compliance) applied more stress on the suture line compared to artery graft (lower 
compliance); although Dacron graft applied even higher stress on the suture line than both artery 
and vein graft.6 This could mean that the force experienced by the vessel depends heavily on the 
graft material property and not just a simple compliance to IH relation. Nevertheless, our 
preliminary observation on the IH formation is based on a rather small sample size and statistical 
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analysis could not be performed. Given a large variation between the animals, a larger sample size 
is required to confirm this finding. 
4.4 Conclusions 
In conclusion, we have successfully implanted small diameter PVA grafts in an end-to-side 
anastomosis configuration. We found that the overall 28- to 30- day patency of PVA grafts (1.9 
cm long, 2 mm ID) was as high as 71% and there was no inflammatory reaction found. However, 
endothelialisation on the graft lumen was not observed which could be the reason of thrombus 
formation in graft lumen. The correlation of IH formation and graft compliance is at the moment 











5.1 General conclusions 
Endothelialisation of a vascular graft can help to improve graft patency by preventing 
platelet and coagulation factors activation. As the performance of small diameter ePTFE graft has 
been disappointing, many other synthetic and composite materials were explored among which 
STMP-crosslinked PVA was chosen to be a promising material to make a small diameter vascular 
graft. However, surface property of PVA needs to be altered to allow for endothelialisation in vitro 
and in vivo. This alteration was done through luminal plasma modification with NH3 plasma 
coupled with surface microtopography 2x2x2 µm gratings and 1.8 µm concave lenses, as both 
topographies were shown previously to have a positive effect on endothelial cell adhesion.23 This 
thesis has shown the potential of NH3 luminal plasma treatment in further improving cell 
adherence without compromising hemocompatibility of PVA grafts. The sterilization study with 
EtO and γ-radiation was conducted to determine the best sterilization method for sterilizing our 
PVA grafts. As shown in sterilization of other materials, EtO sterilization changes PVA 
crystallinity and mechanical property, while γ-radiation does not. More importantly, γ-radiation 
increases water contact angle of PVA and endothelial cell attachment on γ-irradiated 2 µm gratings 
PVA surface was significantly higher than the untreated substrates (with and without pattern) and 
γ-irradiated unpatterned PVA. With the decent improvement in the in vitro endothelialisation of 
PVA and the identification of a suitable sterilization method, small diameter PVA vascular grafts 
were implanted at the rabbit common carotid arteries with an end-to-side anastomosis 
configuration. PVA grafts that were used in this study were unpatterned, γ-irradiated PVA grafts 
with two different compliance ranges for gathering preliminary data on the IH formation. The main 
aim of the in vivo study is to assess whether the longer small diameter PVA graft without surface 
topography could maintain its patency after 28 to 30 days and be endothelialised in vivo without 
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any inflammatory response as cell response to biomaterial surface in vivo may vary from in vitro. 
The 28- to 30-day patency rate of the unpatterned PVA was as high as 71% and no inflammatory 
response was observed. However, endothelialisation on graft lumen was not observed.  
5.2 Recommendations 
Future direction for this thesis work will be to incorporate luminal modification, i.e. NH3 
plasma treatment and/ or 2 µm gratings topography into the small diameter PVA grafts for the in 
vivo study. The in vivo study is still ongoing and eventually sufficient number of animals per 
experimental group will be achieved and statistical significance of the results will be obtained. 
Further improvement on graft patency could be done through identifying the ideal compliance 
range that could minimize IH formation. Vessel ligation should also be made further from the 
anastomosis region to avoid exaggeration of IH formation on the native artery and to allow a better 
assessment of the IH formation on the PVA graft lumen. It is also important to have the means to 
accurately measure the in vivo compliance of the carotid vessel to further evaluate the graft-vessel 
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